Skip to main content
. 2019 Dec 23;28(154):190095. doi: 10.1183/16000617.0095-2019

FIGURE 2.

FIGURE 2

Potential sites of action of phosphodiesterase (PDE) inhibitors and soluble guanylyl cyclase (sGC) activators in airways smooth muscle and inflammatory cells. AC: adenylyl cyclase; (c)AMP: (cyclic) adenosine monophosphate; (c)GMP: (cyclic) guanosine monophosphate; GC: guanylyl cyclase; NO: nitric oxide; PKG: protein kinase G.